Merck Group

Merck Group

Verified
Science and technology in healthcare, life science, performance materials.

Launch date
Employees
Market cap
$218.2b
Net debt
($18b)
Firm valuation
$236.2b (Public information from Oct 2022)
Darmstadt Hesse (HQ)
Deals in current and previous year:
Corporate Venture Fund: M. Ventures

Financials

Edit
Revenues, earnings & profits over time
USD2016201720182019202020212022E
Revenues-40.1b42.3b46.8b48.0b48.7b57.4b
% growth--5 %11 %2 %1 %18 %
EBITDA-15.1b15.8b19.6b20.6b19.8b24.0b
% EBITDA margin-38 %37 %42 %43 %41 %42 %
Profit-2.6b6.2b9.8b7.1b13.0b15.8b
% profit margin-6 %15 %21 %15 %27 %28 %
EV / revenue-4.2x5.1x5.3x4.8x4.0x3.5x
EV / EBITDA-11.2x13.6x12.6x11.2x9.8x8.4x
  • Edit
DateInvestorsAmountRound
N/AN/AIPO
Total Funding-

Recent News about Merck Group

Edit
Investments analysisEdit

Investments by Merck Group

Edit
Idenix Pharmaceuticals
ACQUISITION by Merck Group Jun 2014
Threshold Pharmaceuticals
ACQUISITION by Molecular Templates Aug 2017
Cubist Pharmaceuticals
ACQUISITION by Merck Group Dec 2014
Chord Therapeutics
ACQUISITION by Merck Group Dec 2021
Exelead
ACQUISITION by Merck Group Jan 2022
Amptec
ACQUISITION by Merck Group Jan 2021
View 107 more